Mariner’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.91M | Buy |
15,073
+190
| +1% | +$61.9K | 0.01% | 863 |
|
|
2025
Q1 | $4.02M | Buy |
14,883
+1,217
| +9% | +$329K | 0.01% | 903 |
|
|
2024
Q4 | $3.22M | Buy |
13,666
+1,947
| +17% | +$458K | 0.01% | 980 |
|
|
2024
Q3 | $3.22M | Buy |
11,719
+3,832
| +49% | +$1.05M | 0.01% | 955 |
|
|
2024
Q2 | $1.92M | Buy |
7,887
+993
| +14% | +$241K | ﹤0.01% | 1133 |
|
|
2024
Q1 | $1.03M | Sell |
6,894
-217
| -3% | -$32.4K | ﹤0.01% | 1478 |
|
|
2023
Q4 | $1.36M | Sell |
7,111
-7,070
| -50% | -$1.35M | ﹤0.01% | 1245 |
|
|
2023
Q3 | $2.51M | Sell |
14,181
-3,654
| -20% | -$647K | 0.01% | 888 |
|
|
2023
Q2 | $3.39M | Sell |
17,835
-1,531
| -8% | -$291K | 0.01% | 785 |
|
|
2023
Q1 | $3.88M | Sell |
19,366
-6,298
| -25% | -$1.26M | 0.01% | 716 |
|
|
2022
Q4 | $6.1M | Sell |
25,664
-780
| -3% | -$185K | 0.02% | 537 |
|
|
2022
Q3 | $5.29M | Buy |
+26,444
| New | +$5.29M | 0.02% | 497 |
|